GAMBARAN PENGGUNAAN OBAT HEPATOPROTEKTOR PADA PENYAKIT GANGGUAN FUNGSI HATI DI INSTALASI RAWAT INAP RSU SARILA HUSADA SRAGEN 2019

Danik, Setyowati (2020) GAMBARAN PENGGUNAAN OBAT HEPATOPROTEKTOR PADA PENYAKIT GANGGUAN FUNGSI HATI DI INSTALASI RAWAT INAP RSU SARILA HUSADA SRAGEN 2019. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Danik Setyowati.pdf Restricted to Repository staff only Download (2MB)
	Text KTI.pdf Download (1MB)

Abstract

Impaired liver function is usually caused by disorders of the metabolic system, toxic substances, microbial infections, circulatory disorders and neoplasms. The purpose of this study was to determine the characteristics of liver function disorder patients treated at Sarila Husada Sragen General Hospital in 2019 and to know the use of hepatoprotector drugs in these patients. Data collection was carried out retrospectively through medical records of patients with impaired liver function. The results showed the number of male patients suffering from impaired liver function more than the number of female patients. Patients in the 45-65 years age group dominate cases of liver dysfunction with a percentage of 32.07%. Curcuma is an oral drug that has a high percentage of 41.7% followed by hepatin 35.29% and Epatin 23.52%. Conclusions and from this study the greatest liver function disorder was reactive hepatopathy of 39.62% with the highest concomitant disease that was DHF of 32% and administration of the highest hepatoprotector drug that was an oral-oral combination of 33.96%.

Actions (login required)

View Item